• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Manufacturing
    • Packaging
    • Development
    • Compliance
    • Top 25
    • Directory
    • Microsites
    • Events
    • More
  • Magazine
  • News
  • Manufacturing
  • Packaging
  • Development
  • Compliance
  • Top 25
  • Directory
  • Microsites
  • Events
  • Current / Back Issue
    Features
    Editorial
    Columns
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Subscribe Now
    Advertise Now
    Top Features
    Small Innovators & Niche CROs

    Focus on Science

    Rapid and Data Rich Chromatographic Method Development

    Preparing Your Post Pandemic Talent Strategy

    How Modern Near-Infrared Came to Be
    Breaking News
    Online Exclusives
    Industry News
    Collaborations & Alliances
    Promotions & Moves
    Trials & Filings
    Financial Reports
    Bio News & Views
    Custom Sourcing News
    Packaging & Tracking
    CRO News
    Live From Shows
    Top News
    Frontage Expands Capabilities at its Clinical Site in Secaucus, NJ

    Ascendia Pharmaceuticals Poised for Expansion

    Bora Pharmaceuticals Adds Roller Compaction Capabilities

    Merck KGaA Selects PRA’s Remote Patient Monitoring Platform

    AGC Biologics Appoints Jun Takami GM of Chiba Site
    APIs
    Aseptic Processing
    Cleaning Validation
    Clinical Trial Materials
    Cytotoxics and High Potency Manufacturing
    Equipment
    Excipients
    Extractables and Leachables
    Facilities
    Fill/Finish
    Lyophilization
    Parenterals
    Process Development
    Process Validation
    Risk Management
    Scale-up/ Technology Transfer
    Solid Dosage/ Creams/ Ointments

    Ascendia Pharmaceuticals Poised for Expansion

    Bora Pharmaceuticals Adds Roller Compaction Capabilities

    Alkermes, Merck Enter Clinical Trial and Supply Agreement

    Sterling Pharma Solutions Acquires ADC Biotechnology

    Moderna, Catalent Enter Long-Term Strategic Vax Pact
    Capsules
    Cold Chain Management
    Injectables
    Logistics
    Serialization
    Solid Dosage / Semi-solids
    Supply Chain
    Vials

    Cryoport Acquires Critical Transport Solutions Australia

    PharmParts – This Makes Sense!

    Securing Your API Supply Chain: Three Keys to Success

    Enteris BioPharma: Custom Solutions – From Bench to Market

    The Benefits of Outsourcing Cold Storage
    Analytical Services
    Bioanalytical Services
    Bioassay Developement
    Biologics, Proteins, Vaccines
    Biosimilars
    Chemistry
    Clinical Trials
    Drug Delivery
    Drug Development
    Drug Discovery
    Formulation Development
    Information Technology
    Laboratory Testing
    Methods Development
    Microbiology
    Preclinical Outsourcing
    R&D
    Toxicology

    Frontage Expands Capabilities at its Clinical Site in Secaucus, NJ

    Ascendia Pharmaceuticals Poised for Expansion

    Merck KGaA Selects PRA’s Remote Patient Monitoring Platform

    Agilex Biolabs Acquires TetraQ for APAC Expansion Plans

    Alkermes, Merck Enter Clinical Trial and Supply Agreement
    Filtration & Purification
    GMPs/GCPs
    Inspections
    QA/QC
    Regulatory Affairs
    Validation

    What Will Change at FDA for 2021?

    RBQM Comes of Age: COVID as a Catalyst for Change

    Post-Pandemic Regulations

    Enteris BioPharma: Custom Solutions – From Bench to Market

    Metrics Contract Services Completes Russian Regulatory Inspection
    Companies
    Categories
    Corporate Capabilities
    Add New Company
    Contract Service Directory Companies
    Quotient Sciences

    Almac Group

    Adare Pharma Solutions

    Baxter BioPharma Solutions

    Alcami
    Companies
    News Releases
    Posters
    Brochures
    Services
    Videos
    Case Study
    White Papers
    Jobs
    Contract Service Directory Companies
    Adare Pharma Solutions

    Emergent BioSolutions

    Quotient Sciences

    Alcami

    Almac Group
    Webinars
    Live From Shows
    • Magazine
      • Current / Back Issue
      • Features
      • Editorial
      • Columns
      • Editorial Guidelines
      • Subscribe Now
      • Advertise Now
      • Enewsletter Archive
      • Digital Edition
    • Directory
      • Companies
      • Categories
      • Corporate Capabilities
      • Add Your Company
    • Manufacturing
      • APIs
      • Aseptic Processing
      • Cleaning Validation
      • Clinical Trial Materials
      • Cytotoxics and High Potency Manufacturing
      • Equipment
      • Excipients
      • Extractables and Leachables
      • Facilities
      • Fill/Finish
      • Lyophilization
      • Parenterals
      • Process Development
      • Process Validation
      • Risk Management
      • Scale-up/ Technology Transfer
      • Solid Dosage/ Creams/ Ointments
      • cGMP Manufacture
    • Packaging
      • Capsules
      • Cold Chain Management
      • Injectables
      • Logistics
      • Serialization
      • Solid Dosage / Semi-solids
      • Supply Chain
      • Vials
    • Development
      • Analytical Services
      • Bioanalytical Services
      • Bioassay Developement
      • Biologics, Proteins, Vaccines
      • Biosimilars
      • Chemistry
      • Clinical Trials
      • Drug Delivery
      • Drug Development
      • Drug Discovery
      • Formulation Development
      • Information Technology
      • Laboratory Testing
      • Methods Development
      • Microbiology
      • Preclinical Outsourcing
      • R&D
      • Toxicology
    • Compliance
      • Filtration & Purification
      • GMPs/GCPs
      • Inspections
      • QA/QC
      • Regulatory Affairs
      • Validation
    • Top 25 Pharma & BioPharma
    • Contract Pharma Direct
    • Breaking News
    • Online Exclusives
    • Slideshows
    • Experts Opinions
    • Surveys
      • Outsourcing Survey
      • Salary Survey
    • Glossary
    • Videos
    • Podcasts
    • White Papers
    • Infographics
    • Contract Pharma Conference
      • Contract Pharma Conference
      • Speakers
      • Exhibitors
      • Conference Sessions
    • Supplier Microsite
      • Companies
      • News Releases
      • Posters
      • Brochures
      • Services
      • Videos
      • Case Study
      • White Papers
    • eBook
    • Webinars
    • Events
      • Industry Events
      • Live from Show Events
      • Webinars
    • Classifieds / Job Bank
      • Classifieds
      • Job Bank
    • About Us
      • About Us
      • Contact Us
      • Advertise With Us
      • Privacy Policy
      • Terms of Use
    Breaking News

    Charles River Acquires Retrogenix

    Strengthens scientific expertise with the addition of cell microarray technology and off-target profiling for drug discovery.

    Related CONTENT
    • Kindeva Drug Delivery and Cambridge Healthcare Innovations Collaborate
    • Cryoport Acquires Critical Transport Solutions Australia
    • LabVantage Solutions Expands and Improves its Portfolio
    • What Will Change at FDA for 2021?
    • Servier Acquires Agios Pharmaceuticals’ Oncology Portfolio
    Tim Wright, Editor, Contract Pharma04.05.21
    Charles River Laboratories has acquired early-stage contract research organization (CRO) Retrogenix, a provider of specialized bioanalytical services utilizing its proprietary cell microarray technology, for $48 million.
     
    Based in the UK, Retrogenix offers cell microarray services for target receptor identification, off-target profiling, and target deconvolution on a wide range of novel therapeutics including biologics, cell therapies, and small molecules. Retrogenix’s proprietary cell microarray technology provides a fast, accurate, and effective solution for identifying specific cell surface and secreted protein interactions in human cells. Retrogenix’s technology allows global biopharmaceutical clients to overcome the critical deconvolution step in phenotypic drug discovery; uncover novel, high-quality and exploitable drug targets; and explore preclinical safety liabilities of lead candidates using a comprehensive, off-target screening platform. As part of its cell microarray technology, Retrogenix offers one of the largest protein libraries with over 6,200 human plasma membrane and secreted protein clones, which provides a unique screening tool for discovering primary target receptors and assessing potential off-target binding issues.
     
    The acquisition of Retrogenix enhances Charles River’s scientific expertise with additional large molecule and cell therapy discovery capabilities. Retrogenix provides the premier platform for off-target screening for preclinical safety assurance in CAR T cell therapies. Combined with Distributed Bio’s large-molecule discovery platform, Retrogenix’s capabilities will further strengthen Charles River’s integrated, end-to-end solution for therapeutic antibody and cell and gene therapy discovery and development.
     
    “The acquisition of Retrogenix strategically expands Charles River’s existing discovery capabilities by adding a proprietary cell microarray technology to accelerate target identification and provide preclinical safety assurance for novel therapies,” said James C. Foster, president and CEO, Charles River. “In addition to enhancing our position as the premier, single-source provider for a broad portfolio of discovery services, Retrogenix enhances our ability to support clients’ early-stage drug research efforts in advanced drug modalities, including cell therapies. Retrogenix’s goal is to become the industry standard for receptor identification and off-target screening solutions for biotherapeutics and cell therapies, and we believe the combination with Charles River’s extensive early-stage expertise will enable them to achieve this goal. We are pleased to welcome Retrogenix and its talented staff to the Charles River family.”
    Related Searches
    • Bioanalytical Services
    Suggested For You
    Kindeva Drug Delivery and Cambridge Healthcare Innovations Collaborate Kindeva Drug Delivery and Cambridge Healthcare Innovations Collaborate
    Cryoport Acquires Critical Transport Solutions Australia Cryoport Acquires Critical Transport Solutions Australia
    LabVantage Solutions Expands and Improves its Portfolio LabVantage Solutions Expands and Improves its Portfolio
    What Will Change at FDA for 2021? What Will Change at FDA for 2021?
    Servier Acquires Agios Pharmaceuticals’ Oncology Portfolio Servier Acquires Agios Pharmaceuticals’ Oncology Portfolio
    SK Capital Completes Acquisition of BFS from Catalent Pharma Solutions SK Capital Completes Acquisition of BFS from Catalent Pharma Solutions
    Ajinomoto, Bright Peak Enter Immunocytokines Research Pact Ajinomoto, Bright Peak Enter Immunocytokines Research Pact
    Chime Biologics Expands CDMO Capabilities Chime Biologics Expands CDMO Capabilities
    BioCentriq, Kytopen Enter Cell Therapy Alliance BioCentriq, Kytopen Enter Cell Therapy Alliance
    Eisai Begins Construction of New Injection/Research Building Eisai Begins Construction of New Injection/Research Building
    Small Molecules for Immunology, Oncology & COVID Small Molecules for Immunology, Oncology & COVID
    LabConnect Expands Johnson City Facility LabConnect Expands Johnson City Facility
    Stiris Research Inc. Stiris Research Inc.
    CapsCanada Launches Liquid-Filled Hard Capsule Mfg. Service in North America CapsCanada Launches Liquid-Filled Hard Capsule Mfg. Service in North America
    Genesis Drug Discovery & Development Acquires Integrated Analytical Solutions Genesis Drug Discovery & Development Acquires Integrated Analytical Solutions

    Related Breaking News

    • Analytical Services | Bioanalytical Services | Breaking News | Industry News
      Agilex Biolabs Acquires TetraQ for APAC Expansion Plans

      Agilex Biolabs Acquires TetraQ for APAC Expansion Plans

      Specializes in bioanalysis of small molecules and biologics for PK, immunogenicity, biomarker and immunological pharmacodynamics assessments.
      Kristin Brooks 04.08.21

    • Bioanalytical Services | Breaking News
      Genesis Drug Discovery & Development Acquires Integrated Analytical Solutions

      Genesis Drug Discovery & Development Acquires Integrated Analytical Solutions

      Adds ‘off the shelf’ PK profiling capabilities to its portfolio.
      Charles Sternberg, Assistant Editor 03.04.21

    • Bioanalytical Services | Breaking News | Industry News | Preclinical Outsourcing
      Altasciences Contributes to Vibegron Approval

      Altasciences Contributes to Vibegron Approval

      Provided clinical support for two drug-drug interaction studies and a bioavailability trial for the overactive bladder treatment.
      Kristin Brooks 02.24.21


    • Analytical Services | Bioanalytical Services | Breaking News | Chemistry | Facilities | Industry News | Laboratory Testing | R&D
      Almac Group Completes $7M R&D Center

      Almac Group Completes $7M R&D Center

      Significant expansion of biocatalysis, flow chemistry, and peptide capacity.
      Tim Wright, Editor, Contract Pharma 02.23.21

    • Analytical Services | Bioanalytical Services | Breaking News | Chemistry | Industry News | Laboratory Testing
      Element Materials Technology Acquires Avomeen

      Element Materials Technology Acquires Avomeen

      Bolsters offering in key strategic growth areas, including formulation chemistry, product manufacturing, extractables & leachables, and large molecule testing.
      Kristin Brooks 02.03.21

    • Analytical Services | Bio News | Bioanalytical Services | Breaking News | Industry News | Laboratory Testing
      Frontida Expands Testing Capabilities

      Frontida Expands Testing Capabilities

      Launches CAT.one testing to support abuse-deterrent product development.
      Tim Wright, Editor, Contract Pharma 02.02.21


    • Bio News | Bioanalytical Services | Biologics, Proteins, Vaccines | Breaking News | Industry News | Laboratory Testing
      Almac Expands Global Biologics Testing Services

      Almac Expands Global Biologics Testing Services

      Investment in mass spectrometry support aims to accelerate biologics development and approval.
      Tim Wright, Editor, Contract Pharma 01.27.21

    • Bio News | Bioanalytical Services | Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Facilities | Industry News
      CDMO Northway Biotech Expands in U.S.

      CDMO Northway Biotech Expands in U.S.

      Opens new biopharmaceutical manufacturing site in greater Boston area.
      Tim Wright, Editor, Contract Pharma 01.21.21

    • Bioanalytical Services | Biologics, Proteins, Vaccines | Breaking News | Industry News
      Nexelis Acquires GSK Vax Lab in Marburg

      Nexelis Acquires GSK Vax Lab in Marburg

      Enters into a 5-year strategic agreement to support the development of future GSK vaccine candidates.
      Contract Pharma Staff 01.20.21


    • Bio News | Bioanalytical Services | Biologics, Proteins, Vaccines | Breaking News | Facilities | Industry News
      Fujifilm to Invest $40M in New Facility

      Fujifilm to Invest $40M in New Facility

      State-of-the-art viral vector and advanced therapy process development and manufacturing facility will be located in Boston area.
      Contract Pharma Staff 01.05.21

    • Bioanalytical Services | Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Clinical Trial Materials | Industry News
      Lonza Expands Conjugation Facility in Visp

      Lonza Expands Conjugation Facility in Visp

      Two additional manufacturing suites will provide development and manufacturing capacity for preclinical to commercial supply.
      Contract Pharma Staff 12.21.20

    • Bioanalytical Services | Breaking News | cGMP Manufacture | Industry News
      Passage Bio Invests in Gene Therapy Manufacturing R&D Site

      Passage Bio Invests in Gene Therapy Manufacturing R&D Site

      In combination with dedicated cGMP suite at Catalent, the new lab creates foundation for integrated AAV gene therapy manufacturing.
      Contract Pharma Staff 12.17.20


    • Bio News | Bioanalytical Services | Bioassay Development | Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Collaborations & Alliances | Industry News
      Collaboration Creates Bio Hub in Northern UK

      Collaboration Creates Bio Hub in Northern UK

      CDMO Fujifilm Diosynth Biotechnologies is part of Northern Bio-Accelerator Partnership.
      Contract Pharma Staff 12.16.20

    • Bio News | Bioanalytical Services | Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Facilities | Industry News | Process Development | Scale-up/Technology Transfer
      CHA Biotech Launches Global CDMO Biz

      CHA Biotech Launches Global CDMO Biz

      Matica Biotechnology to construct GMP facility for viral vector production in Texas.
      Contract Pharma Staff 12.16.20

    • Bioanalytical Services | Breaking News | cGMP Manufacture | Industry News
      KBI Biopharma Expands U.S. Ops

      KBI Biopharma Expands U.S. Ops

      Invests $150 million in commercial biologics manufacturing facility in RTP, NC.
      Contract Pharma Staff 12.02.20

    Trending
    • Sterling Pharma Solutions Acquires ADC Biotechnology
    • Sanofi To Build New $700M Flu Vaccine Facility In Canada
    • Alkermes, Merck Enter Clinical Trial And Supply Agreement
    • Ascendia Pharmaceuticals Poised For Expansion
    • Frontage Expands Capabilities At Its Clinical Site In Secaucus, NJ
    Breaking News
    • Bora Pharmaceuticals Adds Roller Compaction Capabilities
    • Ascendia Pharmaceuticals Poised for Expansion
    • Frontage Expands Capabilities at its Clinical Site in Secaucus, NJ
    • Merck KGaA Selects PRA’s Remote Patient Monitoring Platform
    • AGC Biologics Appoints Jun Takami GM of Chiba Site
    View Breaking News >
    CURRENT ISSUE

    April 2021

    • Small Innovators & Niche CROs
    • Focus on Science
    • Rapid and Data Rich Chromatographic Method Development
    • Preparing Your Post Pandemic Talent Strategy
    • How Modern Near-Infrared Came to Be
    • Securing Your API Supply Chain: Three Keys to Success
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    Kyowa Hakko Launches Heat-Treated Probiotic Strain for Eye Health
    CGA-7 Green Coffee Extract by Vidya Herbs Achieves Self-Affirmed GRAS Status
    Nutritional Complex Evidenced to Reduce Preterm Birth
    Coatings World

    Latest Breaking News From Coatings World

    Barentz Expands Canadian CASE Team
    Shepherd Color Company Opens Sales Office in China
    Chromaflo Technologies Awarded Gold Status CSR Rating by EcoVadis in EMEA
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    CMS Establishes New Payment for Pelvalon’s Eclipse System
    Varian, Google Cloud Partner to Bring Convenience to Cancer Therapy
    Resonetics Leases New Manufacturing Space in Costa Rica
    Contract Pharma

    Latest Breaking News From Contract Pharma

    Frontage Expands Capabilities at its Clinical Site in Secaucus, NJ
    Ascendia Pharmaceuticals Poised for Expansion
    Bora Pharmaceuticals Adds Roller Compaction Capabilities
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    Revlon Unveils New Fragrances Featuring Megan Thee Stallion & Sofia Carson
    Henkel Management Board Welcomes Wolfgang König
    Mielle Organics Gets a Major Investment
    Happi

    Latest Breaking News From Happi

    Nature’s Beauty Debuts Vegan Natural Body Care at Walgreens
    Estée Lauder Expands 'Beautiful' Fagrance Collection
    Mushrooms Are Key Ingredients in Beauty & Wellness
    Ink World

    Latest Breaking News From Ink World

    SE-DA Invests in Kornit Presto S
    Kumon North America Adds Speedmaster XL 106 from Heidelberg
    Iron Oxide Pigments Market to Register 4.7% CAGR from 2021 to 2028: GVR
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    Dantex elevates Joseph Sanchez to digital business development manager
    Mactac's Kevin Clunie joins TLMI panel
    MacDermid announces two new global sales roles
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    Precision Textiles Offers Biodegradable Medical Fabric
    Northshore Launches Megamax Briefs in New Colors
    Essity Acquires Distribution Rights to Sorbact in Australia and New Zealand
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    New Biosealant Could Stabilize Cartilage, Boost Healing After Injury
    Google Executive Joins SeaSpine's Board of Directors
    HSS and LimaCorporate Open Provider-Based 3D Design and Printing Facility
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    Tive Multi-sensor Tracker Solo 5G Relies on Sensirion SHT33
    VTT in 2020: Successful Year Despite Globally Challenging Times
    Lux Research: 3D Printing Market to Reach $51 Billion in 2030

    Copyright © 2021 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login